0000059478 2026-05-07 2026-05-07 0000059478 1 2026-05-07 2026-05-07 0000059478 2 2026-05-07 2026-05-07 0000059478 3 2026-05-07 2026-05-07 0000059478 4 2026-05-07 2026-05-07 0000059478 5 2026-05-07 2026-05-07 0000059478 6 2026-05-07 2026-05-07 0000059478 7 2026-05-07 2026-05-07 0000059478 8 2026-05-07 2026-05-07 iso4217:USD pure shares S-3 424B2 EX-FILING FEES 333-285052 0000059478 ELI LILLY & Co N/A N/A S-3 ELI LILLY & Co false Debt Floating Rate Notes due 2028 true 750000000 1.00 750000000.00 0.0001381 103575.00 false Debt Floating Rate Notes due 2029 true 500000000 1.00 500000000.00 0.0001381 69050.00 false Debt 4.150% notes due 2029 true 750000000 0.99941 749557500.00 0.0001381 103513.89 false Debt 4.375% notes due 2031 true 1500000000 0.99893 1498395000.00 0.0001381 206928.35 false Debt 4.650% notes due 2033 true 1250000000 0.99982 1249775000.00 0.0001381 172593.93 false Debt 4.850% notes due 2036 true 1500000000 0.9964 1494600000.00 0.0001381 206404.26 false Debt 5.600% notes due 2056 true 1750000000 0.99726 1745205000.00 0.0001381 241012.81 false Debt 5.700% notes due 2066 true 1000000000 0.99391 993910000.00 0.0001381 137258.97 8981442500.00 1240337.21 0.00 0.00 1240337.21 These "Calculation of Filing Fee Tables" shall be deemed to update the "Calculation of Filing Fee Tables" in Eli Lilly and Company's Registration Statement on Form S-3 (File No. 333-285052), which was filed on February 19, 2025, in accordance with Rules 456(b) and 457(r) under the Securities Act of 1933, as amended. The prospectus supplement to which this exhibit is attached is a final prospectus for the related offering. These "Calculation of Filing Fee Tables" shall be deemed to update the "Calculation of Filing Fee Tables" in Eli Lilly and Company's Registration Statement on Form S-3 (File No. 333-285052), which was filed on February 19, 2025, in accordance with Rules 456(b) and 457(r) under the Securities Act of 1933, as amended. The prospectus supplement to which this exhibit is attached is a final prospectus for the related offering. These "Calculation of Filing Fee Tables" shall be deemed to update the "Calculation of Filing Fee Tables" in Eli Lilly and Company's Registration Statement on Form S-3 (File No. 333-285052), which was filed on February 19, 2025, in accordance with Rules 456(b) and 457(r) under the Securities Act of 1933, as amended. The prospectus supplement to which this exhibit is attached is a final prospectus for the related offering. These "Calculation of Filing Fee Tables" shall be deemed to update the "Calculation of Filing Fee Tables" in Eli Lilly and Company's Registration Statement on Form S-3 (File No. 333-285052), which was filed on February 19, 2025, in accordance with Rules 456(b) and 457(r) under the Securities Act of 1933, as amended. The prospectus supplement to which this exhibit is attached is a final prospectus for the related offering. These "Calculation of Filing Fee Tables" shall be deemed to update the "Calculation of Filing Fee Tables" in Eli Lilly and Company's Registration Statement on Form S-3 (File No. 333-285052), which was filed on February 19, 2025, in accordance with Rules 456(b) and 457(r) under the Securities Act of 1933, as amended. The prospectus supplement to which this exhibit is attached is a final prospectus for the related offering. These "Calculation of Filing Fee Tables" shall be deemed to update the "Calculation of Filing Fee Tables" in Eli Lilly and Company's Registration Statement on Form S-3 (File No. 333-285052), which was filed on February 19, 2025, in accordance with Rules 456(b) and 457(r) under the Securities Act of 1933, as amended. The prospectus supplement to which this exhibit is attached is a final prospectus for the related offering. These "Calculation of Filing Fee Tables" shall be deemed to update the "Calculation of Filing Fee Tables" in Eli Lilly and Company's Registration Statement on Form S-3 (File No. 333-285052), which was filed on February 19, 2025, in accordance with Rules 456(b) and 457(r) under the Securities Act of 1933, as amended. The prospectus supplement to which this exhibit is attached is a final prospectus for the related offering. These "Calculation of Filing Fee Tables" shall be deemed to update the "Calculation of Filing Fee Tables" in Eli Lilly and Company's Registration Statement on Form S-3 (File No. 333-285052), which was filed on February 19, 2025, in accordance with Rules 456(b) and 457(r) under the Securities Act of 1933, as amended. The prospectus supplement to which this exhibit is attached is a final prospectus for the related offering. 8981442500.00 true